Mode
Text Size
Log in / Sign up

Smoking, aging, and CRP levels associated with cataract and AMD comorbidity risk in 640 participantsStudy links smoking and aging to higher risk of cataract and macular degeneration

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider using this ML model for risk stratification, noting associations only and limited generalizability.

This retrospective case-control study assessed risk factors for the comorbidity of cataract and age-related macular degeneration among 640 participants, comprising 264 cases and 376 controls. The analysis examined exposures including smoking, aging, C-reactive protein (CRP) levels, drusen severity, and lens opacity measured via LOCS III. A machine learning model utilizing XGBoost was trained and validated to stratify comorbidity risk.

The model demonstrated robust discriminative performance with an area under the curve (AUC) of 0.895 (95% CI: 0.85–0.93). Analysis of the interaction between smoking and aging revealed a non-linear synergistic effect, indicating exponentially higher comorbidity risk in individuals aged over 75 years. Additionally, a distinct saturation threshold effect was observed regarding CRP levels.

Safety data, including adverse events, discontinuations, and tolerability, were not reported in this study. Key limitations include the retrospective design and the inability to explicitly distinguish between association and causation. The study describes findings as 'associated with' or 'synergistic effects' rather than causal relationships. Generalizability beyond the 640 participants is uncertain.

This research establishes a robust, clinically applicable risk stratification tool for cataract and AMD comorbidity. Clinicians should interpret these results as associations derived from observational data rather than proof of causation. The model's performance metrics provide a basis for risk assessment within the specific population studied.

This research looked at 640 participants, including 264 people with both cataract and age-related macular degeneration and 376 controls without these conditions. Scientists examined factors like smoking history, aging, inflammation levels, and eye changes to understand the risk of having both eye diseases at the same time. They used a machine learning model to predict who was at higher risk based on these factors.

The analysis showed that the model performed well at distinguishing between those with and without both conditions. A key finding was that the risk of having both diseases increases exponentially for people over 75 who also smoke. Additionally, higher levels of a protein called C-reactive protein were linked to risk, but only up to a certain point before the effect leveled off.

While this study provides a useful tool for doctors to identify patients at higher risk, it is important to remember the study design. Because the data was collected after the events happened, researchers could not prove that smoking or aging directly caused the diseases. Readers should view these results as showing connections between habits and health, not as absolute proof of cause and effect.

What this means for you:
Smoking and older age are linked to higher risk of both cataract and macular degeneration in this study.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundThe comorbidity of cataract and age-related macular degeneration (AMD) poses a significant public health burden. Traditional linear statistical models often fail to capture complex, non-linear interactions among risk factors. This study aimed to develop an interpretable machine learning framework to predict comorbidity risk and elucidate the synergistic effects of systemic and ocular factors.MethodsA retrospective case-control study was conducted involving 640 participants (264 comorbidity cases and 376 controls). Fifteen multi-dimensional clinical features were extracted. Four machine learning algorithms—Logistic Regression, Random Forest, SVM, and XGBoost—were trained and validated. Model performance was assessed via AUROC, AUPRC, and calibration curves. SHapley Additive exPlanations (SHAP) and LIME were employed to visualize global and local interpretability.ResultsThe XGBoost model demonstrated robust discriminative performance (AUC = 0.895, 95% CI: 0.85–0.93) and calibration compared to other algorithms. SHAP analysis identified drusen severity and lens opacity (LOCS III) as dominant ocular predictors, while C-reactive protein (CRP) and smoking were critical systemic contributors. Notably, interaction analysis revealed a non-linear synergistic effect: smoking was associated with an exponentially higher comorbidity risk in individuals aged >75 years, whereas CRP exhibited a distinct saturation threshold effect. Decision curve analysis confirmed the model's high net clinical benefit across a wide range of threshold probabilities.ConclusionThis study establishes a robust, clinically applicable risk stratification tool for cataract and AMD comorbidity. By uncovering non-linear interactions between aging, lifestyle, and inflammation, it provides valuable evidence-based support for personalized screening and preventive intervention.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.